to DNA but that hydrogen bonds play less of a role. In vitro cytotoxic activities for these complexes do not always follow the trends that would be expected on the basis of the adduct profiles.
Introduction
Although it has been widely accepted that the binding of Pt(ll) to DNA is ultimately responsible for the anticancer activity of Pt based anticancer drugs [1] [2] [3] [4] , the factors that control the DNA binding and how these influence the anticancer activity are poorly understood [5] . For example, molecular models and some crystal structures reveal hydrogen bonds between the oxygen atoms of DNA and the amine ligands that remain bound to Pt [6] [7] [8] [9] [10] [11] [12] [13] . On the basis of these observations it has been proposed that the ability to form such hydrogen bonds is required for DNA binding and anticancer activity [9, 14] . This suggestion is consistent with the observation that replacement of all H atoms on the amine groups with alkyl groups greatly diminishes the anticancer activity [15] but is not consistent with the increasing number of compounds that are active but do not have H(amine) atoms. An alternative explanation is that it is the small size of the H(amine) atoms rather than their hydrogen bonding ability that is important [5, 16] but the role of steric factors in mediating Pt/DNA interactions has received relatively little attention.
To date, most studies of Pt/DNA interactions have focused on the final products but to gain an understanding of what controls the product distribution each step needs to be examined. The overwhelmingly preferred binding sites are the GpG and ApG sequences [17] [18] [19] [20] [21] and there are indications that sequences with more than two guanine bases are favoured [22, 23] . Binding to isolated guanine bases is inherently preferred over binding to isolated adenine bases [24] but outer-sphere complex formation prior to binding also has the potential to influence the final product distribution. If this is the case then the bases flanking a binding site could control binding and ultimately determine the effectiveness of the drug in terms of its ability to bind to a particular sequence and produce an anticancer effect.
In the present paper we summarise [27] . They also studied the reaction of cisplatin with oligonucleotides and found a higher rate of binding to the 3' guanine of a GpG pair and faster closure to the bifunctional adduct from this base [28, 29] .
(1 [30] . A typical spectrum showing starting materials, intermediates and the final product for reaction at the ApG site is shown in Figure 1 and a plot showing the appearance and disappearance of each of these species is shown in Figure 2 . Similar plots were obtained for the reaction at the GpA site. Rate constants for each step were extracted from numerically optimised fits to these data curves and the calculated curves are also shown in Figure 2 . Calculated rate constants are listed in Table along with those reported previously for reaction at the GpG site [28, 29] . Rates of monofunctional adduct formation at the ApG site are broadly similar to those at the GpG site. Binding at the 3'-G is more rapid than binding to the 3'-G of the GpG sequence and binding at the 5'-A is remarkably similar in rate to binding at the 5'-G of GpG. In contrast rates of monofunctional binding to GpA site are markedly slower. Thus, binding at the 3'-A is two orders of magnitude slower than binding to the 3'-G's of GpG and ApG and binding at the 5'-G is nearly an order of magnitude slower than is binding to the 3'-bases of GpG and ApG. Some tentative conclusions can be drawn from these results; (i) the normal preference for binding to guanine over adenine can be substantially affected by both flanking sequences and the DNA structure, (ii) the base on the 3' side of a binding site exerts a substantially greater influence on the rate of binding than does the base on the 5' side and (iii) the rates of monofunctional adduct formation are an important determinant of the final adduct profile. Rates of closure to the bifunctional adduct are remarkably similar for all three sequences and follow the same trends. Thus closure from the 3' side is faster, ranging from 1.6 to 3.2 x 10 -s , than closure from the 5' side that ranges from 0.18 to 0.24 x 10 -s-. The constancy of these rates is despite the fact that the bases are guanine in some cases and adenine in others providing further evidence that the DNA structure can overrule the inherent preference for binding to guanine over adenine. They also show that the major reason for the nonformation of the bifunctional GpA adduct is the slow rate of formation of the monofunctional adduct, though this is further exacerbated by the fact that the more rapidly formed monofunctional adduct at the GpA sequence is the one that closes more slowly to the bifunctional adduct. [35] . 1D and 2D NMR spectra of these two peaks showed them to be isomers of the expected [Pt(GpG)(hpip)] complex [35] . Two isomers are expected because of the asymmetry of the hpip and GpG ligands. Close contacts between the H8 atoms of the GpG and protons on either the ethylene or propylene links on the backbone of the hpip ligands were evident in the NOESY spectra and these allowed us to identify the isomers [35] . Peak corresponds to the isomer in which the propylene link is adjacent to the floor of the major groove of the DNA and ieak II to the isomer in which the ethylene link adopts this position. Molecular mechanics models of each of these isomers on a DNA fragment show substantial differences in the severity of the steric clashes between the linking groups and the DNA [36] . Thus Obtaining compounds that meet these design goals has proven difficult. Chirality at the amine groups is unstable and therefore ligands with inert chiral centres adjacent to the amine were chosen in the expectation that they would impose the required chirality via atropisomerism. Our first target compounds, [PtCl(2,4-pentanediamine)] and [PtCI(N,N'-dimethyl-l,2-cyclohexanediamine)], did not meet these requirements because two diastereomers were observed in each case [31] . However, variants of the ahaz ligand (ahaz = 3-aminohexahydroazepine, Scheme V), were successful in that the undesired diastereomer accounted for less than 5% of the complexes [33] . The endocyclic nature of one of the amine groups means the chirality at that centre is rigorously imposed and an alkyl group on the exocyclic amine adopts the orientation that gives rise to the required trans hydrogen atoms more than 95% of the time.
Cl.,,,il__,l,,,.Cl H / Scheme V In the first phase of this study we studied the enantiomers of the parent complex [PtCl(ahaz)]. As with [PtCl(hpip)], the inequivalence of the amine groups of the ahaz ligand means that two GpG adducts are observed for each enantiomer as shown in Scheme VI. The amounts of each of these formed, measured by enzymatic digestion and HPLC separation, are also shown in Scheme VI. For the R-enantiomer the two isomers are observed in approximately equal amounts but for the S-enantiomer the amounts differ substantially, one being similar to the R enantiomer and the other more that three times as abundant. Using 2D-NMR spectroscopy were have established that the most abundant adduct is the one in which the exocyclic NH group of the S-enantiomer is oriented toward the 5' side of the adduct (S(a) in Scheme VI). Molecular mechanics models of the four isomers provided a possible explanation for these observations because for R(a), R(b) and S(b) substantial steric clashes are observed between the ligands and the DNA but for S(a) the entire ligand lies in the major groove and makes no close contacts with the DNA. Thus, these results provide further support for the notion that steric clashes between the complex and DNA can exert a significant influence on the adduct profile. They also provide evidence that the ability to form hydrogen bonds may not be as important because for each of the R isomers only one of the hydrogen bonds is able to form whereas for each of the S isomers both hydrogen bonds can form but the amounts of each isomer formed do not correlate with the number of hydrogen bonds that can form. The S-enantiomer forms substantially more bifunctional GpG adducts (37%) than does the Renantiomer (21%). Thus, if this adduct was responsible for effecting the anti-cancer activity, then the S-enantiomer would be expected to be more active. We have measured the activity of the both enantiomers against a number of cell lines and the results are given in Table II1 .
In nearly all cases the two enantiomers have similar activities and in some cases the Renantiomer appears to be the more active, in contrast to the expectations outlined above. Other factors such as cellular uptake could contribute to these results but we have shown that there is no enantioselective difference in the uptake [32] . Alternatively, it has been suggested that anti-cancer activity depends on the ability of proteins to recognise adducts and initiate events that lead to cell death [37] . It may be that the additional steric interactions observed for the R-enantiomer lead to additional bending of the DNA that in turn lead to better recognition. In vitro cytotoxicities of complexes of the substituted ahaz complexes (Scheme VII) are given in Table IV [33] . Addition of a methyl or ethyl group to the exocyclic amine results in a nearly five-fold drop in the activity of the complexes. This is in contradiction to the structure-activity rule that high activity is usually observed when each amine group has one or more hydrogen atoms. When two methyl groups are added to the exocyclic nitrogen the activity does not change significantly compared to the value for a single added methyl group. Again, this is unexpected because structure-activity rules suggest that removal of both hydrogen atoms from one of the amine groups should lead to a substantial drop in the cytotoxicity (a) 9 
